Jci_page_head_homepage_01 Jci_page_head_homepage_02
Takashi Nomiyama, Diego Perez-Tilve, Daisuke Ogawa, Florence Gizard, Yue Zhao, Elizabeth B. Heywood, Karrie L. Jones, Ryuzo Kawamori, Lisa A. Cassis, Matthias H. Tschöp, Dennis Bruemmer
Published in Volume 117, Issue 10
J Clin Invest. 2007; 117(10):2877–2888 doi:10.1172/JCI31986
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
OPN plasma levels in DIO and expression of OPN in adipose tissue.

C57BL/6 mice (n = 10/group) were fed a LFD or HFD for 20 weeks. (A) OPN plasma levels were analyzed by ELISA and data expressed as mean ± SEM. #P < 0.005. (B) Adipose tissues were isolated and OPN mRNA expression was analyzed in whole EWAT, the AF, and the SVF. Data are presented as relative OPN mRNA expression normalized to TFIIB mRNA expression and are expressed as mean ± SEM. *P < 0.05, compared with LFD. (C) SVFs isolated from EWATs of obese wild-type mice (n = 6) were pooled and separated into macrophages, endothelial cells, and preadipocytes using magnetic immunoaffinity isolation. Cell fractions were analyzed for OPN (black bars, left y axis) and CD68 (white bars, right y axis) mRNA expression. Data are presented as mRNA expression relative to TFIIB mRNA expression and are expressed as mean ± SEM. **P < 0.01 compared with preadipocyte or endothelial cell fraction. (D) Paraffin-embedded EWAT was analyzed for OPN immunoreactivity and F4/80-positive macrophage content. Sections were counterstained with hematoxylin and images obtained at the indicated magnifications.